Provided by Tiger Trade Technology Pte. Ltd.

Warren Buffett holdings

3,248.53
+12.710.39%
Number of Gainers:31
Number of Losers:4
Number of Flat:- -
PE:- -
High:3,257.53
Open:3,234.79
Low:3,230.74
Close:3,235.82
Volume:360.94M
Turnover:44.73B
Market Cap:11.56T
Float Cap:10.98T

Loading ...

Constellation says could land at high end of guidance if trends continue

TIPRANKS
·
Oct 07

Constellation Brands Shares Reverse Premarket Losses, Last up About 3% After Q2 Results Beat

THOMSON REUTERS
·
Oct 07

Charter’s Spectrum Community Solutions Signs Long-Term Deal with DMB Development for Pre-Installed Internet at Silverwood Community

Reuters
·
Oct 07

Dolby Laboratories' Atmos Spatial Audio to Be Used on Apple TV's Formula 1 Broadcasts

MT Newswires Live
·
Oct 07

Morgan Stanley Adjusts Price Target on Merck to $177 From $179

MT Newswires Live
·
Oct 07

Mizuho Adjusts Price Target on Aon to $324 From $366

MT Newswires Live
·
Oct 07

Citi Wealth CIO Sees Higher-for-Longer Rates, Stays Underweight Duration

Reuters
·
Oct 07

Sector Update: Consumer

MT Newswires Live
·
Oct 07

India's Jubilant FoodWorks Posts Higher Quarterly Revenue as Domino's Sales Pick Up

Reuters
·
Oct 07

Dollar Climbs Ahead of Fed Minutes; Euro Slides Towards 17-Month Lows

Reuters
·
Oct 07

BofA Securities Adjusts Ally Financial Price Target to $44 From $49

MT Newswires Live
·
Oct 07

AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations

TIPRANKS
·
Oct 07

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Oct 07

Halozyme announces Dutch court of the Hague found Merck infringed patents

TIPRANKS
·
Oct 07

AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer

Reuters
·
Oct 07

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Reuters
·
Oct 07

Analysts Offer Insights on Consumer Cyclical Companies: MTY Food Group (OtherMTYFF) and Amazon (AMZN)

TIPRANKS
·
Oct 07

Halozyme Therapeutics - Iv Version of Keytruda Remains Available and not Covered by Halozyme's Patent or Court Injunction

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Court Rejects Merck's Arguments That Ep622 Patent is Invalid

THOMSON REUTERS
·
Oct 07

Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda Sc in Multiple European Markets

THOMSON REUTERS
·
Oct 07